One-step Breast Cancer Treatment Combines Radiation, Surgery

Key points
- Princess Margaret Hospital (PMH) breast cancer specialists are using a new way to treat patients by delivering a one-time dose of radiation during surgery.
- On May 17, the PMH team combined the expertise of surgeons, radiation medicine specialists (radiation oncologists, physicists and therapists) and nurses to perform its first procedure.
- “The potential benefits to patients are huge,” says lead surgeon Dr.
- Here’s how it works: Using a probe attached to the portable intrabeam radiotherapy machine, a single, concentrated dose is inserted directly into the affected area inside the breast during surgery.
Princess Margaret Hospital (PMH) breast cancer specialists are using a new way to treat patients by delivering a one-time dose of radiation during surgery. The procedure, called intraoperative radiation therapy, takes less than an hour and eliminates the need for further radiation treatments.
On May 17, the PMH team combined the expertise of surgeons, radiation medicine specialists (radiation oncologists, physicists and therapists) and nurses to perform its first procedure. It marked the first time the portable intrabeam radiotherapy machine that makes this procedure possible has been used in Canada. The PMH team has since treated two more patients.
“The potential benefits to patients are huge,” says lead surgeon Dr. David McCready, who also heads the PMH Breast Cancer Program. “Treating the specific area of cancer with this kind of precision protects the skin, heart and lungs from unnecessary radiation, minimizes side effects, and saves the patient a lot of time.”
Here’s how it works: Using a probe attached to the portable intrabeam radiotherapy machine, a single, concentrated dose is inserted directly into the affected area inside the breast during surgery. Dr. McCready says the one-time dose is “biologically equivalent” to conventional radiation treatments for breast cancer that typically require, on average, a minimum of 16 treatments over three weeks.
Dr. Anthony Fyles, the radiation oncologist who leads the Breast Radiation Oncology Program and treated the first patient in the operating room that day, says: “This procedure is helping us understand more about the biology of how breast tissue responds to treatment. That knowledge, in turn, will help us further customize and select the best treatment options for individuals with early breast cancer.”
Next, Drs. McCready and Fyles will join a randomized clinical trial to further study the results of using this procedure. The study participants from PMH will generally be older patients with small, early-stage tumours (less than 2 cm). The revolutionary technique was pioneered four years ago in Britain, where more than 800 women are now part of an international trial.
Princess Margaret Hospital and its research arm, Ontario Cancer Institute, have achieved an international reputation as global leaders in the fight against cancer. Princess Margaret Hospital is a member of the University Health Network, which also includes Toronto General Hospital and Toronto Western Hospital. All three are research hospitals affiliated with the University of Toronto.
Source: University Health Network (UHN)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
News25% don’t complete recommended breast cancer treatment
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of…
10 April 2013
NewsLess invasive treatment may increase survival in early stage breast cancer
Patients with early stage breast cancer who are treated with lumpectomy plus radiation have a better chance of survival compared with those who undergo mastectomy, according to Duke Medicine research. The study, which…
29 January 2013
NewsThe factor that could influence future breast cancer treatment
Australian scientists have shown in the laboratory how a 'transcription factor' causes breast cancer cells to develop an aggressive subtype that lacks sensitivity to estrogen and does not respond to known anti-estrogen…
30 December 2012


